Imaging the vulnerable plaque: A scintillating light at the end of the tunnel?

Journal of Nuclear Medicine

Volumn 45, Issue 7, 2004, Pages 1106-1107

  Strauss, H William ^a   Dunphy, Mark ^a   Tokita, Naoki ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN V TC 99M; FLUORODEOXYGLUCOSE F 18; LIPOCORTIN 5; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANGIOSCOPY; AORTA; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; ECHOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTILLATION; SHORT SURVEY; THROMBOGENESIS; THROMBOSIS; ANIMAL; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; MACROPHAGE; METABOLISM; NOTE; RABBIT; SCINTISCANNING;

ANIMALS; CAROTID ARTERY DISEASES; CAROTID STENOSIS; FLUORODEOXYGLUCOSE F18; HUMANS; MACROPHAGES; RABBITS; RADIOPHARMACEUTICALS;

EID: 4043176293     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Davies MJ. Stability and instability: two faces of coronary atherosclerosis - The Paul Dudley White Lecture 1995. Circulation. 1996;94:2013-2020.
2. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol. 2001;37:1284-1288.
3. Spagnoli LG, Bonanno E, Mauriello A, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2002;40:1579-1588.
4. Davies MJ. Atlas of Coronary Artery Disease. Philadelphia, PA: Lippincott Raven; 1999.
5. Libby PF. The vascular biology of atherosclerosis. In: Braunwald EB, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, PA: WB Saunders and Co.; 2001:chap 30.
6. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
7. Smith S Jr. Risk-reduction therapy: the challenge to change. Circulation. 1996;93:2205-2211.
8. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-1322.
9. Davies MJ. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J. 1995;16(suppl L):3-7.
10. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15:439-446.
11. Katsuda S, Kaji T. Atherosclerosis and extracellular matrix. J Atheroscler Thromb. 2003;10:267-274.
12. Bard RL, Kalsi H, Rubenfire M, et al. Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention. Am J Cardiol. 2004;93:1030-1032.
13. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
14. Stanford W, Thompson BH, Burns TL, Heery SD, Burr MC. Coronary artery calcium quantification at multi-detector row helical CT versus electron-beam CT. Radiology. 2004;230:397-402.
15. Luo Y, Polissar N, Han C, et al. Accuracy and uniqueness of three in vivo measurements of atherosclerotic carotid plaque morphology with black blood MRI. Magn Reson Med. 2003;50:75-82.
16. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
17. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
18. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837.
19. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;32:70-76.
20. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-1250.
21. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 1980;118:81-84.
22. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9-23.
23. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:24-34.
24. Spagnoli LG, Orlandi A, Mauriello A, et al. Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis. 1991;89:11-24.
25. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 1998;95:6349-6354.
26. Kietselaer BLJH, Reutelingsperger CPM, Heidendal GAK, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med. 2004;350:1472-1473.
27. -/- mice [abstract]. J Nucl Med. 2002;43(suppl):1P.